Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05438134 · ClinicalTrials.gov registry record · NA
Enhancing Resilience in Senior Community Residents
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 288
- Enrollment target
NCT05438134: Completed NA study, sponsored by Massachusetts General Hospital.
NCT05438134 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 288 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05438134, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
Study Summary
This randomized waitlist-controlled trial tests the efficacy of the Stress Management and Resiliency Training Relaxation Response Resiliency Program (SMART-3RP), a mind-body intervention, to enhance resilience and flourishing among residents in continuing care retirement communities. The investigators hypothesize that participants in the SMART-3RP group will report greater increases in resilience and flourishing relative to participants in the control group.
Interventions
- BEHAVIORAL SMART-3RP Group Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2022-06-24 |
| Est. Completion | 2023-04-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05438134
The ClinicalTrials.gov registry entry for NCT05438134 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SMART-3RP Group Intervention is the first listed.
NCT05438134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05438134 about?
NCT05438134 is a clinical study titled "Enhancing Resilience in Senior Community Residents". This randomized waitlist-controlled trial tests the efficacy of the Stress Management and Resiliency Training Relaxation Response Resiliency Program (SMART-3RP), a mind-body intervention, to enhance resilience and flourishing among residents in continuing care retirement communities. The investigato...
What is the current status of trial NCT05438134?
This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2022-06-24. Estimated completion is 2023-04-05.
What interventions are being tested in trial NCT05438134?
The interventions under investigation include: SMART-3RP Group Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05438134?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.